局部晚期宫颈癌多中心定量MRI的体模质量控制框架
该研究设计并测试了一套基于体模测量的质量控制(QA)框架,用于局部晚期宫颈癌多中心成像生物标志物试验的定量MRI协议。结果显示T2和ADC值在协议差异下仍可保持一致测量,而DCE-MRI和基于可变翻转角法的T1定量更具挑战性。
要点
- T2和ADC值在协议差异下仍可保持一致的测量,T1和DCE-MRI一致性较差。
- DCE-MRI中幅度数据呈非线性厂商特异性关系,相位数据呈线性关系。
核心结论
- 基于体模的QA框架可用于多中心定量MRI协议验证,T2和ADC值在协议差异下仍可保持一致测量。
- DCE-MRI和基于可变翻转角法的T1定量在多中心间保持一致测量更具挑战性。
研究设计与样本
- 各机构按系统条件、机构偏好和研究特定约束优化T2、DWI、T1和DCE-MRI协议。
- 使用已知值的校准体模进行验证,并采用各系统相似的基准协议区分机构协议差异与系统差异。
- 计算偏倚、重复性(%RC)和再现性(%RDC),T2和T1值采用比值。
主要发现
- 机构协议下T2偏倚范围为0.88-0.98,中位%RC=1%,%RDC=12%。
- ADC偏倚范围为-0.007至0.029×10-3 mm2/s,中位%RC=3%,%RDC=18%。
- T1偏倚范围为0.39-1.29,中位%RC=1%,%RDC=33%。
- DCE-MRI中幅度数据呈非线性厂商特异性关系,相位数据呈线性关系。
临床怎么用
- 在多中心定量MRI研究中,可采用基于体模的QA框架验证T2和ADC协议的一致性。
- 对DCE-MRI和T1 mapping需谨慎解读多中心数据,因一致性更具挑战性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: A wide variation of MRI systems is a challenge in multicenter imaging biomarker studies as it adds variation in quantitative MRI values. The aim of this study was to design and test a quality assurance (QA) framework based on phantom measurements, for the quantitative MRI protocols of a multicenter imaging biomarker trial of locally advanced cervical cancer. MATERIALS AND METHODS: Fifteen institutes participated (five 1.5 T and ten 3 T scanners). Each institute optimized protocols for T2, diffusion-weighted imaging, T1, and dynamic contrast-enhanced (DCE-)MRI according to system possibilities, institutional preferences and study-specific constraints. Calibration phantoms with known values were used for validation. Benchmark protocols, similar on all systems, were used to investigate whether differences resulted from variations in institutional protocols or from system variations. Bias, repeatability (%RC), and reproducibility (%RDC) were determined. Ratios were used for T2 and T1 values. RESULTS: The institutional protocols showed a range in bias of 0.88-0.98 for T2 (median %RC = 1%; %RDC = 12%), -0.007 to 0.029 × 10-3 mm2/s for the apparent diffusion coefficient (median %RC = 3%; %RDC = 18%), and 0.39-1.29 for T1 (median %RC = 1%; %RDC = 33%). For DCE a nonlinear vendor-specific relation was observed between measured and true concentrations with magnitude data, whereas the relation was linear when phase data was used. CONCLUSION: We designed a QA framework for quantitative MRI protocols and demonstrated for a multicenter trial for cervical cancer that measurement of consistent T2 and apparent diffusion coefficient values is feasible despite protocol differences. For DCE-MRI and T1 mapping with the variable flip angle method, this was more challenging.
引用
- van Houdt PJ, Kallehauge JF, Tanderup K, et al. Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancer. Radiother Oncol. 2020. PMID: 32931890. doi:10.1016/j.radonc.2020.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。